Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Aug;39(2):255–261. doi: 10.1136/gut.39.2.255

Antiproliferative effects of interferon alpha on human pancreatic carcinoma cell lines are associated with differential regulation of protein kinase C isoenzymes.

S Rosewicz 1, M Weder 1, A Kaiser 1, E O Riecken 1
PMCID: PMC1383308  PMID: 8977340

Abstract

BACKGROUND: The molecular mechanisms mediating the antiproliferative effects of interferon alpha on human pancreatic carcinoma cells are poorly understood. AIM: To characterise the effects of interferon alpha on protein kinase C isoenzyme expression in interferon alpha sensitive and resistant human pancreatic tumour cell lines. METHODS: The ductal human pancreatic carcinoma cell lines Capan 1 and Capan 2 were investigated. Anchorage dependent and independent growth was determined by cell number and a human tumour clonogenic assay. Interferon alpha receptor expression was examined by reverse-transcriptase polymerase chain reaction and electrophoretic mobility shift assay. Protein kinase C isoenzyme expression was evaluated by western blotting using monospecific polyclonal antibodies. RESULTS: Interferon alpha treatment results in a time and dose dependent inhibition of anchorage dependent and independent growth in Capan 1 cells while Capan 2 cells were not affected by interferon alpha. Both cell lines express interferon alpha receptor mRNA transcripts. Growth inhibition by interferon alpha in Capan 1 cells was paralleled by a profound decrease of protein kinase C alpha and zeta expression while these isoenzymes were unaffected in the interferon resistant cell line Capan 2. CONCLUSION: Inhibition of protein kinase C isoenzyme expression might determine the sensitivity of a given pancreatic carcinoma to respond to the antiproliferative action of interferon alpha.

Full text

PDF
255

Images in this article

258Figure 4
on p.258
258Figure 5
on p.258
259Figure 6
on p.259
260Figure 7
on p.260

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akita Y., Ohno S., Yajima Y., Suzuki K. Possible role of Ca2(+)-independent protein kinase C isozyme, nPKC epsilon, in thyrotropin-releasing hormone-stimulated signal transduction: differential down-regulation of nPKC epsilon in GH4C1 cells. Biochem Biophys Res Commun. 1990 Oct 15;172(1):184–189. doi: 10.1016/s0006-291x(05)80191-3. [DOI] [PubMed] [Google Scholar]
  2. Andrews N. C., Faller D. V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991 May 11;19(9):2499–2499. doi: 10.1093/nar/19.9.2499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arbuck S. G. Chemotherapy for pancreatic cancer. Baillieres Clin Gastroenterol. 1990 Dec;4(4):953–968. doi: 10.1016/0950-3528(90)90029-g. [DOI] [PubMed] [Google Scholar]
  4. Bakkevold K. E., Arnesjø B., Kambestad B. Carcinoma of the pancreas and papilla of Vater: presenting symptoms, signs, and diagnosis related to stage and tumour site. A prospective multicentre trial in 472 patients. Norwegian Pancreatic Cancer Trial. Scand J Gastroenterol. 1992 Apr;27(4):317–325. doi: 10.3109/00365529209000081. [DOI] [PubMed] [Google Scholar]
  5. Benzil D. L., Finkelstein S. D., Epstein M. H., Finch P. W. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression. Cancer Res. 1992 May 15;52(10):2951–2956. [PubMed] [Google Scholar]
  6. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  7. Constantinescu S. N., Cernescu C., Balta F., Maniu H., Popescu L. M. The priming effect of human interferon-alpha is mediated by protein kinase C. J Interferon Res. 1990 Dec;10(6):589–597. doi: 10.1089/jir.1990.10.589. [DOI] [PubMed] [Google Scholar]
  8. Csermely P., Balint E., Grimley P. M., Aszalos A. Protein kinase C is involved in the early signals of interferon-alpha but not of interferon-gamma in U937 cells. J Interferon Res. 1990 Dec;10(6):605–611. doi: 10.1089/jir.1990.10.605. [DOI] [PubMed] [Google Scholar]
  9. Eldar H., Zisman Y., Ullrich A., Livneh E. Overexpression of protein kinase C alpha-subtype in Swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epidermal growth factor. J Biol Chem. 1990 Aug 5;265(22):13290–13296. [PubMed] [Google Scholar]
  10. Gresser I. Antitumour effects of interferons: past, present and future. Br J Haematol. 1991 Oct;79 (Suppl 1):1–5. doi: 10.1111/j.1365-2141.1991.tb08108.x. [DOI] [PubMed] [Google Scholar]
  11. Hug H., Sarre T. F. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J. 1993 Apr 15;291(Pt 2):329–343. doi: 10.1042/bj2910329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jelkmann W., Huwiler A., Fandrey J., Pfeilschifter J. Inhibition of erythropoietin production by phorbol ester is associated with down-regulation of protein kinase C-alpha isoenzyme in hepatoma cells. Biochem Biophys Res Commun. 1991 Sep 30;179(3):1441–1448. doi: 10.1016/0006-291x(91)91734-t. [DOI] [PubMed] [Google Scholar]
  13. Katayama N., Nishikawa M., Minami N., Shirakawa S. Putative involvement of protein kinase C in proliferation of human myeloid progenitor cells. Blood. 1989 Jan;73(1):123–130. [PubMed] [Google Scholar]
  14. Kessler D. S., Levy D. E. Protein kinase activity required for an early step in interferon-alpha signaling. J Biol Chem. 1991 Dec 5;266(34):23471–23476. [PubMed] [Google Scholar]
  15. Kikkawa U., Kishimoto A., Nishizuka Y. The protein kinase C family: heterogeneity and its implications. Annu Rev Biochem. 1989;58:31–44. doi: 10.1146/annurev.bi.58.070189.000335. [DOI] [PubMed] [Google Scholar]
  16. Kumar R., Korutla L., Zhang K. Cell cycle-dependent modulation of alpha-interferon-inducible gene expression and activation of signaling components in Daudi cells. J Biol Chem. 1994 Oct 14;269(41):25437–25441. [PubMed] [Google Scholar]
  17. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992 Oct 23;258(5082):607–614. doi: 10.1126/science.1411571. [DOI] [PubMed] [Google Scholar]
  18. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature. 1988 Aug 25;334(6184):661–665. doi: 10.1038/334661a0. [DOI] [PubMed] [Google Scholar]
  19. Ohmura E., Okada M., Onoda N., Kamiya Y., Murakami H., Tsushima T., Shizume K. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res. 1990 Jan 1;50(1):103–107. [PubMed] [Google Scholar]
  20. Ohmura E., Wakai K., Isozaki O., Murakami H., Onoda N., Emoto N., Shizume K., Tsushima T., Demura H., Robins R. K. Inhibition of human pancreatic cancer cell (MIA PaCa-2) growth by cholera toxin and 8-chloro-cAMP in vitro. Br J Cancer. 1993 Feb;67(2):279–283. doi: 10.1038/bjc.1993.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Persons D. A., Owen R. D., Ostrowski M. C., Finn O. J. Protein kinase C gamma expression mimics phorbol ester-induced transcriptional activation of a murine VL30 enhancer element. Cell Growth Differ. 1991 Jan;2(1):7–14. [PubMed] [Google Scholar]
  22. Pfeffer L. M., Eisenkraft B. L., Reich N. C., Improta T., Baxter G., Daniel-Issakani S., Strulovici B. Transmembrane signaling by interferon alpha involves diacylglycerol production and activation of the epsilon isoform of protein kinase C in Daudi cells. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):7988–7992. doi: 10.1073/pnas.88.18.7988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pfeffer L. M., Strulovici B., Saltiel A. R. Interferon-alpha selectively activates the beta isoform of protein kinase C through phosphatidylcholine hydrolysis. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6537–6541. doi: 10.1073/pnas.87.17.6537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rosewicz S., Stier U., Brembeck F., Kaiser A., Papadimitriou C. A., Berdel W. E., Wiedenmann B., Riecken E. O. Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology. 1995 Nov;109(5):1646–1660. doi: 10.1016/0016-5085(95)90655-x. [DOI] [PubMed] [Google Scholar]
  25. Rustum Y. M. Rational basis for the metabolic modulation of 5-fluorouracil by leucovorin and interferon alpha. Br J Haematol. 1991 Oct;79 (Suppl 1):52–55. doi: 10.1111/j.1365-2141.1991.tb08120.x. [DOI] [PubMed] [Google Scholar]
  26. Schüssler M. H., Skoudy A., Ramaekers F., Real F. X. Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol. 1992 Mar;140(3):559–568. [PMC free article] [PubMed] [Google Scholar]
  27. Sen G. C., Lengyel P. The interferon system. A bird's eye view of its biochemistry. J Biol Chem. 1992 Mar 15;267(8):5017–5020. [PubMed] [Google Scholar]
  28. Silverberg E., Boring C. C., Squires T. S. Cancer statistics, 1990. CA Cancer J Clin. 1990 Jan-Feb;40(1):9–26. [PubMed] [Google Scholar]
  29. Stabel S., Parker P. J. Protein kinase C. Pharmacol Ther. 1991;51(1):71–95. doi: 10.1016/0163-7258(91)90042-k. [DOI] [PubMed] [Google Scholar]
  30. Uzé G., Lutfalla G., Gresser I. Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell. 1990 Jan 26;60(2):225–234. doi: 10.1016/0092-8674(90)90738-z. [DOI] [PubMed] [Google Scholar]
  31. Wadler S., Schwartz E. L. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res. 1990 Jun 15;50(12):3473–3486. [PubMed] [Google Scholar]
  32. Wilke H., Stahl M., Schmoll H. J., Preusser P., Fink U., Meyer H. J., Achterrath W., Knipp H., Köhne-Wömpner C. H., Harstrick A. Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancer. Semin Oncol. 1992 Apr;19(2 Suppl 3):215–219. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES